Ministry, AstraZeneca cooperate to improve lung health in Vietnam
The Health Ministry and AstraZeneca have signed a cooperation pact to implement the “Healthy Lung” programme in Vietnam, funded by the multinational biopharmaceutical company.
At the signing of cooperation pact for the Healthy Lung programme between the Health Ministry and AstraZeneca company. (Photo: baochinhphu.vn)
Hanoi (VNA) – The HealthMinistry and AstraZeneca have signed a cooperation pact to implement the“Healthy Lung” programme in Vietnam, funded by the multinationalbiopharmaceutical company.
The signing ceremony for thethree-year programme took place in Hanoi on October 18.
The pact marked the health body’sinvolvement in the 1-million-USD programme, which was launched last month by AstraZeneca,the Vietnam Medical Association, the Vietnam Respiratory Society and theVietnam Association against Tuberculosis and Lung Diseases.
“Healthy Lung”, as part of anAstraZeneca global initiative, aims to enhance management and public awarenessof asthma and chronic obstructive pulmonary disease (COPD), contributing toreducing cases and deaths.
Under the programme, AstraZeneca willsponsor the building of 150 outpatient centres treating the diseases tofacilitate early detection and treatment. The outpatient treatment network isexpected to reduce economic and health care burdens for Vietnam.
Under the deal, the ministry willwork with AstraZeneca and other partners to hold training courses and seminars,providing updated information for public health workers nationwide.
A national survey showed that about4.2 percent of the Vietnamese population suffers from COPD, while many others areyet to be diagnosed and treated due to poor infrastructure, limited publicawareness, and weak health sector capacity. The research said only 43.9 percentof polled Vietnamese doctors could name four COPD diagnosis criteria.-VNA
The Da Nang’s Oncology Hospital, in cooperation with the biopharmaceutical firm AstraZeneca, has launched its first-ever Epidermal growth factor receptor (EGFR) mutation testing programme.
As many as 150 outpatient centres treating chronic asthma and chronic obstructive pulmonary disease (COPD) will be built at total investment of 1 million USD by AstraZeneca multinational pharmaceutical and biopharmaceutical company under the “Health lung” programme.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.